Retraction notice to Neuronal damage, central cholinergic dysfunction and oxidative damage correlate with cognitive deficits in rats with chronic cerebral hypoperfusion [Neurobiology of Learning and Memory, 109, (2014), 7-19] Doi: 10.1016/j.nlm.2013.11.016;Neuronal damage, central cholinergic dysfunction and oxidative damage correlate with cognitive deficits in rats with chronic cerebral hypoperfusion

Neurobiology of Learning and Memory

Volumn 109, Issue , 2014, Pages 7-19

  Xi, Ye ^a   Wang, Man ^a   Zhang, Wei ^a   Bai, Miao ^a   Du, Ying ^a   Zhang, Zhuo ^a   Li, Zhuyi ^a   Miao, Jianting ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Cholinergic function; Chronic cerebral hypoperfusion; Cognitive deficit; Oxidative stress; Vascular dementia

Indexed keywords

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC DYSFUNCTION; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN DISEASE; CELL LOSS; CENTRAL CHOLINERGIC DYSFUNCTION; CHRONIC CEREBRAL HYPOPERFUSION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; GLIA CELL; HIPPOCAMPAL CA1 REGION; MALE; MEMORY DISORDER; NERVE CELL LESION; NONHUMAN; OXIDATIVE STRESS; RAT; SPATIAL LEARNING; WORKING MEMORY;

ALZHEIMER'S DISEASE; CHOLINERGIC FUNCTION; CHRONIC CEREBRAL HYPOPERFUSION; COGNITIVE DEFICIT; OXIDATIVE STRESS; VASCULAR DEMENTIA;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ANIMALS; CEREBROVASCULAR DISORDERS; CHOLINE O-ACETYLTRANSFERASE; CHRONIC DISEASE; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY DISORDERS; NEUROGLIA; NEURONS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84890849135     PISSN: 10747427     EISSN: 10959564     Source Type: Journal    
DOI: 10.1016/j.nlm.2015.11.001     Document Type: Erratum

References (108)

1. Alegret M., Vinyes-Junqué G., Boada M., Martínez-Lage P., Cuberas G., Espinosa A., et al. Brain perfusion correlates of visuoperceptual deficits in mild cognitive impairment and mild Alzheimer's disease. Journal of Alzheimers Disease 2010, 21:557-567.
2. Annaházi A., Mracskó E., Süle Z., Karg E., Penke B., Bari F., et al. Pre-treatment and post-treatment with alpha-tocopherol attenuates hippocampal neuronal damage in experimental cerebral hypoperfusion. European Journal of Pharmacology 2007, 571:120-128.
3. Austin B.P., Nair V.A., Meier T.B., Xu G., Rowley H.A., Carlsson C.M., et al. Effects of hypoperfusion in Alzheimer's disease. Journal of Alzheimers Disease 2011, 26:123-133.
4. Avrova N.F., Victorov I.V., Tyurin V.A., Zakharova I.O., Sokolova T.V., Andreeva N.A., et al. Inhibition of glutamate-induced intensification of free radical reactions by gangliosides: Possible role in their protective effect in rat cerebellar granule cells and brain synaptosomes. Neurochemical Research 1998, 23:945-952.
5. Bennett S., Grant M.M., Aldred S. Oxidative stress in vascular dementia and Alzheimer's disease: A common pathology. Journal of Alzheimers Disease 2009, 17:245-257.
6. Bennett S.A., Tenniswood M., Chen J.H., Davidson C.M., Keyes M.T., Fortin T., et al. Chronic cerebral hypoperfusion elicits neuronal apoptosis and behavioral impairment. NeuroReport 1998, 9:161-166.
7. Bierer L.M., Haroutunian V., Gabriel S., Knott P.J., Carlin L.S., Purohit D.P., et al. Neurochemical correlates of dementia severity in Alzheimer's disease: Relative importance of the cholinergic deficits. Journal of Neurochemistry 1995, 64:749-760.
8. Borroni B., Anchisi D., Paghera B., Vicini B., Kerrouche N., Garibotto V., et al. Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD. Neurobiology of Aging 2006, 27:24-31.
9. Breteler M.M. Vascular risk factors for Alzheimer's disease: An epidemiologic perspective. Neurobiology of Aging 2000, 21:153-160.
10. Butterfield D.A., Reed T., Newman S.F., Sultana R. Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radical Biology and Medicine 2007, 43:658-677.
11. Cankurtaran M., Yavuz B.B., Cankurtaran E.S., Halil M., Ulger Z., Ariogul S. Risk factors and type of dementia: Vascular or Alzheimer?. Archives of Gerontology and Geriatrics 2008, 47:25-34.
12. Casado A., Encarnación López-Fernández M., Concepción Casado M., de La Torre R. Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias. Neurochemical Research 2008, 33:450-458.
13. Cechetti F., Pagnussat A.S., Worm P.V., Elsner V.R., Ben J., da Costa M.S., et al. Chronic brain hypoperfusion causes early glial activation and neuronal death, and subsequent long-term memory impairment. Brain Research Bulletin 2012, 87:109-116.
14. Cechetti F., Worm P.V., Lovatel G., Moysés F., Siqueira I.R., Netto C.A. Environmental enrichment prevents behavioral deficits and oxidative stress caused by chronic cerebral hypoperfusion in the rat. Life Sciences 2012, 91:29-36.
15. Chan P.H. Reactive oxygen radicals in signaling and damage in the ischemic brain. Journal of Cerebral Blood Flow and Metabolism 2001, 21:2-14.
16. Choi B.R., Lee S.R., Han J.S., Woo S.K., Kim K.M., Choi D.H., et al. Synergistic memory impairment through the interaction of chronic cerebral hypoperfusion and amlyloid toxicity in a rat model. Stroke 2011, 42:2595-2604.
17. Choy M., Ganesan V., Thomas D.L., Thornton J.S., Proctor E., King M.D., et al. The chronic vascular and haemodynamic response after permanent bilateral common carotid occlusion in newborn and adult rats. Journal of Cerebral Blood Flow and Metabolism 2006, 26:1066-1075.
18. Dash P.K., Moore A.N., Kobori N., Runyan J.D. Molecular activity underlying working memory. Learning & Memory 2007, 14:554-563.
19. Deiana S., Platt B., Riedel G. The cholinergic system and spatial learning. Behavioural Brain Research 2011, 221:389-411.
20. de la Torre J.C. Alzheimer's disease is a vasocognopathy: A new term to describe its nature. Neurological Research 2004, 26:517-524.
21. de la Torre J.C. Vascular basis of Alzheimer's pathogenesis. Annals of the New York Academy of Sciences 2002, 977:196-215.
22. de la Torre J.C., Aliev G. Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion: Spatial memory and immunocytochemical changes. Journal of Cerebral Blood Flow and Metabolism 2005, 25:663-672.
23. De Jong G.I., Farkas E., Stienstra C.M., Plass J.R., Keijser J.N., de la Torre J.C., et al. Cerebral hypoperfusion yields capillary damage in the hippocampal CA1 area that correlates with spatial memory impairment. Neuroscience 1999, 91:203-210.
24. Dheen S.T., Kaur C., Ling E.A. Microglial activation and its implications in the brain diseases. Current Medicinal Chemistry 2007, 14:1189-1197.
25. Du J., Ma M., Zhao Q., Fang L., Chang J., Wang Y., et al. Mitochondrial bioenergetic deficits in the hippocampi of rats with chronic ischemia-induced vascular dementia. Neuroscience 2013, 231:345-352.
26. Egashira T., Takayama F., Yamanaka Y. Effects of bifemelane on muscarinic receptors and choline acetyltransferase in the brains of aged rats following chronic cerebral hypoperfusion induced by permanent occlusion of bilateral carotid arteries. Japanese Journal of Pharmacology 1996, 72:57-65.
27. Farkas E., Donka G., de Vos R.A., Mihály A., Bari F., Luiten P.G. Experimental cerebral hypoperfusion induces white matter injury and microglial activation in the rat brain. Acta Neuropathologica 2004, 108:57-64.
28. Farkas E., Luiten P.G. Cerebral microvascular pathology in aging and Alzheimer's disease. Progress in Neurobiology 2001, 64:575-611.
29. Farkas E., Luiten P.G., Bari F. Permanent, bilateral common carotid artery occlusion in the rat: A model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Research Reviews 2007, 54:162-180.
30. Floyd R.A., Carney J.M. Free radical damage to protein and DNA: Mechanisms involved and relevant observations on brain undergoing oxidative stress. Annals of Neurology 1992, 32:S22-27.
31. Gackowski D., Rozalski R., Siomek A., Dziaman T., Nicpon K., Klimarczyk M., et al. Oxidative stress and oxidative DNA damage is characteristic for mixed Alzheimer disease/vascular dementia. Journal of the Neurological Sciences 2008, 266:57-62.
32. Garcia-Alloza M., Gregory J., Kuchibhotla K.V., Fine S., Wei Y., Ayata C., et al. Cerebrovascular lesions induce transient β-amyloid deposition. Brain 2011, 134:3697-3707.
33. Hanyu H., Sato T., Hirao K., Kanetaka H., Iwamoto T., Koizumi K. The progression of cognitive deterioration and regional cerebral blood flow patterns in Alzheimer's disease: A longitudinal SPECT study. Journal of the Neurological Sciences 2010, 290:96-101.
34. He X.L., Wang Y.H., Bi M.G., Du G.H. Chrysin improves cognitive deficits and brain damage induced by chronic cerebral hypoperfusion in rats. European Journal of Pharmacology 2012, 680:41-48.
35. He X.L., Wang Y.H., Gao M., Li X.X., Zhang T.T., Du G.H. Baicalein protects rat brain mitochondria against chronic cerebral hypoperfusion-induced oxidative damage. Brain Research 2009, 1249:212-221.
36. Hirao K., Ohnishi T., Hirata Y., Yamashita F., Mori T., Moriguchi Y., et al. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT. Neuroimage 2005, 28:1014-1021.
37. Huang L., He Z., Guo L., Wang H. Improvement of cognitive deficit and neuronal damage in rats with chronic cerebral ischemia via relative long-term inhibition of rho-kinase. Cellular and Molecular Neurobiology 2008, 28:757-768.
38. Humpel C., Marksteiner J. Cerebrovascular damage as a cause for Alzheimer's disease. Current Neurovascular Research 2005, 2:341-347.
39. Jaspers R.M., Block F., Heim C., Sontag K.H. Spatial learning is affected by transient occlusion of common carotid arteries (2VO): Comparison of behavioural and histopathological changes after '2VO' and 'four-vessel-occlusion' in rats. Neuroscience Letters 1990, 117:149-153.
40. Jhoo J.H., Kim K.W., Huh Y., Lee S.B., Park J.H., Lee J.J., et al. Prevalence of dementia and its subtypes in an elderly urban korean population: Results from the Korean Longitudinal Study on Health And Aging (KLoSHA). Dementia and Geriatric Cognitive Disorders 2008, 26:270-276.
41. Jiwa N.S., Garrard P., Hainsworth A.H. Experimental models of vascular dementia and vascular cognitive impairment: A systematic review. Journal of Neurochemistry 2010, 115:814-828.
42. Kalaria R.N., Akinyemi R., Ihara M. Does vascular pathology contribute to Alzheimer changes?. Journal of the Neurological Sciences 2012, 322:141-147.
43. Kasparová S., Brezová V., Valko M., Horecký J., Mlynárik V., Liptaj T., et al. Study of the oxidative stress in a rat model of chronic brain hypoperfusion. Neurochemistry International 2005, 46:601-611.
44. Kato H., Yoshikawa T., Oku N., Imaizumi M., Takasawa M., Kimura Y., et al. Statistical parametric analysis of cerebral blood flow in vascular dementia with small-vessel disease using Tc-HMPAO SPECT. Cerebrovascular Diseases 2008, 26:556-562.
45. Keller J.N., Schmitt F.A., Scheff S.W., Ding Q., Chen Q., Butterfield D.A., et al. Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 2005, 64:1152-1156.
46. Kim H.A., Miller A.A., Drummond G.R., Thrift A.G., Arumugam T.V., Phan T.G., et al. Vascular cognitive impairment and Alzheimer's disease: Role of cerebral hypoperfusion and oxidative stress. Naunyn Schmiedebergs Arch Pharmacol 2012, 385:953-959.
47. Kövari E., Gold G., Herrmann F.R., Canuto A., Hof P.R., Bouras C., et al. Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia. Neurology 2007, 68:927-931.
48. Kume K., Hanyu H., Sato T., Hirao K., Shimizu S., Kanetaka H., et al. Vascular risk factors are associated with faster decline of Alzheimer disease: A longitudinal SPECT study. Journal of Neurology 2011, 258:1295-1303.
49. Lai A.Y., Todd K.G. Microglia in cerebral ischemia: Molecular actions and interactions. Canadian Journal of Physiology and Pharmacology 2006, 84:49-59.
50. Li Y., He Y., Guan Q., Liu W., Han H., Nie Z. Disrupted iron metabolism and ensuing oxidative stress may mediate cognitive dysfunction induced by chronic cerebral hypoperfusion. Biological Trace Element Research 2012, 150:242-248.
51. Liao Y., Wang R., Tang X.C. Centrophenoxine improves chronic cerebral ischemia induced cognitive deficit and neuronal degeneration in rats. Acta Pharmacologica Sinica 2004, 25:1590-1596.
52. Liu C., Wu J., Gu J., Xiong Z., Wang F., Wang J., et al. Baicalein improves cognitive deficits induced by chronic cerebral hypoperfusion in rats. Pharmacology, Biochemistry and Behavior 2007, 86:423-430.
53. Liu H., Xing A., Wang X., Liu G., Li L. Regulation of β-amyloid level in the brain of rats with cerebrovascular hypoperfusion. Neurobiology of Aging 2012, 33:e31-42.
54. Liu H., Zhang J. Cerebral hypoperfusion and cognitive impairment: The pathogenic role of vascular oxidative stress. International Journal of Neuroscience 2012, 122:494-499.
55. Love S. Oxidative stress in brain ischemia. Brain Pathology 1999, 9:119-131.
56. Matsuda H. Cerebral blood flow and metabolic abnormalities in Alzheimer's disease. Annals of Nuclear Medicine 2001, 15:85-92.
57. Mazza M., Marano G., Traversi G., Bria P., Mazza S. Primary cerebral blood flow deficiency and Alzheimer's disease: Shadows and lights. Journal of Alzheimers Disease 2011, 23:375-389.
58. Micheau J., Marighetto A. Acetylcholine and memory: A long, complex and chaotic but still living relationship. Behavioural Brain Research 2011, 221:424-429.
59. Mizoguchi K., Shoji H., Tanaka Y., Maruyama W., Tabira T. Age-related spatial working memory impairment is caused by prefrontal cortical dopaminergic dysfunction in rats. Neuroscience 2009, 162:1192-1201.
60. Moretti A., Gorini A., Villa R.F. Pharmacotherapy and prevention of vascular dementia. CNS & Neurological Disorders: Drug Targets 2011, 10:370-390.
61. Mracskó E., Hugyecz M., Institóris A., Farkas E., Bari F. Changes in pro-oxidant and antioxidant enzyme levels during cerebral hypoperfusion in rats. Brain Research 2010, 1321:13-19.
62. Murakami Y., Tanaka E., Sakai Y., Matsumoto K., Li H.B., Watanabe H. Tacrine improves working memory deficit caused by permanent occlusion of bilateral common carotid arteries in rats. Japanese Journal of Pharmacology 1997, 75:443-446.
63. Murakami Y., Zhao Q., Harada K., Tohda M., Watanabe H., Matsumoto K. Choto-san, a Kampo formula, improves chronic cerebral hypoperfusion-induced spatial learning deficit via stimulation of muscarinic M1 receptor. Pharmacology, Biochemistry and Behavior 2005, 81:616-625.
64. Nunn J., Hodges H. Cognitive deficits induced by global cerebral ischaemia: Relationship to brain damage and reversal by transplants. Behavioural Brain Research 1994, 65:1-31.
65. Okamoto Y., Yamamoto T., Kalaria R.N., Senzaki H., Maki T., Hase Y., et al. Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts. Acta Neuropathologica 2012, 123:381-394.
66. Olsen G.M., Scheel-Krüger J., Møller A., Jensen L.H. Relation of spatial learning of rats in the Morris water maze task to the number of viable CA1 neurons following four-vessel occlusion. Behavioral Neuroscience 1994, 108:681-690.
67. Otori T., Katsumata T., Muramatsu H., Kashiwagi F., Katayama Y., Terashi A. Long-term measurement of cerebral blood flow and metabolism in a rat chronic hypoperfusion model. Clinical and Experimental Pharmacology and Physiology 2003, 30:266-272.
68. Ozacmak V.H., Barut F., Ozacmak H.S. Melatonin provides neuroprotection by reducing oxidative stress and HSP70 expression during chronic cerebral hypoperfusion in ovariectomized rats. Journal of Pineal Research 2009, 47:156-163.
69. Pappas B.A., de la Torre J.C., Davidson C.M., Keyes M.T., Fortin T. Chronic reduction of cerebral blood flow in the adult rat: Late-emerging CA1 cell loss and memory dysfunction. Brain Research 1996, 708:50-58.
70. Peng Y., Xu S., Chen G., Wang L., Feng Y., Wang X. L-3-n-Butylphthalide improves cognitive impairment induced by chronic cerebral hypoperfusion in rats. Journal of Pharmacology and Experimental Therapeutics 2007, 321:902-910.
71. Perry E., Walker M., Grace J., Perry R. Acetylcholine in mind: A neurotransmitter correlate of consciousness?. Trends in Neurosciences 1999, 22:273-280.
72. Perry E., Ziabreva I., Perry R., Aarsland D., Ballard C. Absence of cholinergic deficits in "pure" vascular dementia. Neurology 2005, 64:132-133.
73. Pimentel-Coelho P.M., Michaud J.P., Rivest S. Effects of mild chronic cerebral hypoperfusion and early amyloid pathology on spatial learning and the cellular innate immune response in mice. Neurobiology of Aging 2013, 34:679-693.
74. Ruan C.J., Li Z., Zhang L., Chen D.H., Du G.H., Sun L. Protective effects of trans-2, 4-dimethoxystibene on cognitive, impairments induced by Abeta(25-35) in, hypercholesterolemic rats. Brain Research Bulletin 2010, 82:251-258.
75. Sadoshima S., Ibayashi S., Fujii K., Nagao T., Sugimori H., Fujishima M. Inhibition of acetylcholinesterase modulates the autoregulation of cerebral blood flow and attenuates ischemic brain metabolism in hypertensive rats. Journal of Cerebral Blood Flow and Metabolism 1995, 15:845-851.
76. Sarter M., Bruno J.P. Developmental origins of the age-related decline in cortical cholinergic function and associated cognitive abilities. Neurobiology of Aging 2004, 25:1127-1139.
77. Sayan-Ozacmak H., Ozacmak V.H., Barut F., Jakubowska-Dogru E. Rosiglitazone treatment reduces hippocampal neuronal damage possibly through alleviating oxidative stress in chronic cerebral hypoperfusion. Neurochemistry International 2012, 61:287-290.
78. Sekita A., Ninomiya T., Tanizaki Y., Doi Y., Hata J., Yonemoto K., et al. Trends in prevalence of Alzheimer's disease and vascular dementia in a Japanese community: The Hisayama Study. Acta Psychiatrica Scandinavica 2010, 122:319-325.
79. Shim Y.S., Yang D.W., Kim B.S., Shon Y.M., Chung Y.A. Comparison of regional cerebral blood flow in two subsets of subcortical ischemic vascular dementia: Statistical parametric mapping analysis of SPECT. Journal of the Neurological Sciences 2006, 250:85-91.
80. Shinotoh H., Namba H., Fukushi K., Nagatsuka S., Tanaka N., Aotsuka A., et al. Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: A positron emission tomography study. Annals of Neurology 2000, 48:194-200.
81. Sopala M., Danysz W. Chronic cerebral hypoperfusion in the rat enhances age-related deficits in spatial memory. Journal of Neural Transmission 2001, 108:1445-1456.
82. Suter O.C., Sunthorn T., Kraftsik R., Straubel J., Darekar P., Khalili K., et al. Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke 2002, 33:1986-1992.
83. Tanaka K., Ogawa N., Asanuma M., Kondo Y., Nomura M. Relationship between cholinergic dysfunction and discrimination learning disabilities in Wistar rats following chronic cerebral hypoperfusion. Brain Research 1996, 729:55-65.
84. Tanaka K., Wada N., Hori K., Asanuma M., Nomura M., Ogawa N. Chronic cerebral hypoperfusion disrupts discriminative behavior in acquired-learning rats. Journal of Neuroscience Methods 1998, 84:63-68.
85. Tomimoto H., Ihara M., Wakita H., Ohtani R., Lin J.X., Akiguchi I., et al. Chronic cerebral hypoperfusion induces white matter lesions and loss of oligodendroglia with DNA fragmentation in the rat. Acta Neuropathologica 2003, 106:527-534.
86. Tsuchiya M., Sako K., Yura S., Yonemasu Y. Cerebral blood flow and histopathological changes following permanent bilateral carotid artery ligation in Wistar rats. Experimental Brain Research 1992, 89:87-92.
87. Tsuchiya M., Sako K., Yura S., Yonemasu Y. Local cerebral glucose utilisation following acute and chronic bilateral carotid artery ligation in Wistar rats: Relation to changes in local cerebral blood flow. Experimental Brain Research 1993, 95:1-7.
88. Ulrich P.T., Kroppenstedt S., Heimann A., Kempski O. Laser-Doppler scanning of local cerebral blood flow and reserve capacity and testing of motor and memory functions in a chronic 2-vessel occlusion model in rats. Stroke 1998, 29:2412-2420.
89. Vicente E., Degerone D., Bohn L., Scornavaca F., Pimentel A., Leite M.C., et al. Astroglial and cognitive effects of chronic cerebral hypoperfusion in the rat. Brain Research 2009, 1251:204-212.
90. Wakita H., Tomimoto H., Akiguchi I., Kimura J. Glial activation and white matter changes in the rat brain induced by chronic cerebral hypoperfusion: An immunohistochemical study. Acta Neuropathologica 1994, 87:484-492.
91. Wakita H., Tomimoto H., Akiguchi I., Matsuo A., Lin J.X., Ihara M., et al. Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat. Brain Research 2002, 924:63-70.
92. Wang J., Zhang H.Y., Tang X.C. Cholinergic deficiency involved in vascular dementia: Possible mechanism and strategy of treatment. Acta Pharmacologica Sinica 2009, 30:879-888.
93. Wang J., Zhang H.Y., Tang X.C. Huperzine a improves chronic inflammation and cognitive decline in rats with cerebral hypoperfusion. Journal of Neuroscience Research 2010, 88:807-815.
94. Wang X., Xing A., Xu C., Cai Q., Liu H., Li L. Cerebrovascular hypoperfusion induces spatial memory impairment, synaptic changes, and amyloid-β oligomerization in rats. Journal of Alzheimers Disease 2010, 21:813-822.
95. Watanabe T., Zhang N., Liu M., Tanaka R., Mizuno Y., Urabe T. Cilostazol protects against brain white matter damage and cognitive impairment in a rat model of chronic cerebral hypoperfusion. Stroke 2006, 37:1539-1545.
96. Xing B., Chen H., Zhang M., Zhao D., Jiang R., Liu X., et al. Ischemic postconditioning inhibits apoptosis after focal cerebral ischemia/reperfusion injury in the rat. Stroke 2008, 39:2362-2369.
97. Xiong L., Zhang J.J., Sun D., Liu H. Therapeutic benefit of Yangxue Qingnao Granule on cognitive impairment induced by chronic cerebral hypoperfusion in rats. Chinese Journal of Integrated Medicine 2011, 17:134-140.
98. Xu Y., Zhang J.J., Xiong L., Zhang L., Sun D., Liu H. Green tea polyphenols inhibit cognitive impairment induced by chronic cerebral hypoperfusion via modulating oxidative stress. Journal of Nutritional Biochemistry 2010, 21:741-748.
99. Yang D.W., Kim B.S., Park J.K., Kim S.Y., Kim E.N., Sohn H.S. Analysis of cerebral blood flow of subcortical vascular dementia with single photon emission computed tomography: Adaptation of statistical parametric mapping. Journal of the Neurological Sciences 2002, 203-204:199-205.
100. Yao Z.H., Zhang J.J., Xie X.F. Enriched environment prevents cognitive impairment and tau hyperphosphorylation after chronic cerebral hypoperfusion. Current Neurovascular Research 2012, 9:176-184.
101. Yuen E.Y., Liu W., Karatsoreos I.N., Feng J., McEwen B.S., Yan Z. Acute stress enhances glutamatergic transmission in prefrontal cortex and facilitates working memory. Proceedings of the National Academy of Sciences USA 2009, 106:14075-14079.
102. Zhang G.L., Deng J.P., Wang B.H., Zhao Z.W., Li J., Gao L., et al. Gypenosides improve cognitive impairment induced by chronic cerebral hypoperfusion in rats by suppressing oxidative stress and astrocytic activation. Behavioural Pharmacology 2011, 22:633-644.
103. Zhang W., Bai M., Xi Y., Hao J., Liu L., Mao N., et al. Early memory deficits precede plaque deposition in APPswe/PS1dE9 mice: Involvement of oxidative stress and cholinergic dysfunction. Free Radical Biology and Medicine 2012, 52:1443-1452.
104. Zhang W., Hao J., Liu R., Zhang Z., Lei G., Su C., et al. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease. Behavioural Brain Research 2011, 222:342-350.
105. Zhang W., Zhang W., Li Z., Hao J., Zhang Z., Liu L., et al. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice. Pharmacology, Biochemistry and Behavior 2012, 100:361-369.
106. Zhao Q., Murakami Y., Tohda M., Obi R., Shimada Y., Matsumoto K. Chotosan, a kampo formula, ameliorates chronic cerebral hypoperfusion-induced deficits in object recognition behaviors and central cholinergic systems in mice. Journal of Pharmacology Science 2007, 103:360-373.
107. Zito G., Polimanti R., Panetta V., Ventriglia M., Salustri C., Siotto M.C., et al. Antioxidant status and APOE genotype as susceptibility factors for neurodegeneration in Alzheimer's disease and vascular dementia. Rejuvenation Research 2013, 16:51-56.
108. Zlokovic B.V. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nature Reviews Neuroscience 2011, 12:723-738.